Tocilizumab, a proposed therapy for the cachexia of Interleukin6-expressing lung cancer
about
Skeletal muscle wasting and renewal: a pivotal role of myokine IL-6Potential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancerTreatment with anti-IL-6 receptor antibody prevented increase in serum hepcidin levels and improved anemia in mice inoculated with IL-6-producing lung carcinoma cellsCitrus unshiu peel extract alleviates cancer-induced weight loss in mice bearing CT-26 adenocarcinoma.Cancer prevention and therapy through the modulation of the tumor microenvironment.Role of interleukin-6 in cachexia: therapeutic implications.Obesity, adipokines and cancer: an update.Necroinflammation in Kidney Disease.Muscle wasting as main evidence of energy impairment in cancer cachexia: future therapeutic approaches.An in vitro model demonstrates the potential of neoplastic human germ cells to influence the tumour microenvironment.Role of interleukin-6 in cancer progression and therapeutic resistance.Novel therapeutic options for cachexia and sarcopenia.Quality of Life in Patients With Advanced Cancer: Differential Association With Performance Status and Systemic Inflammatory Response.Blockade of the IL-6 trans-signalling/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinoma.Combined Metabolomics and Transcriptomics Approaches to Assess the IL-6 Blockade as a Therapeutic of ALS: Deleterious Alteration of Lipid Metabolism.CGI-99 promotes breast cancer metastasis via autocrine interleukin-6 signaling.Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancerIdentification of Candidate Biomarkers Correlated With the Pathogenesis and Prognosis of Non-small Cell Lung Cancer via Integrated Bioinformatics AnalysisMyokines as Possible Therapeutic Targets in Cancer Cachexia
P2860
Q26743557-9B0473B1-E31E-4D61-8A3E-0B8AEF5CE2FDQ26769917-76B81F70-82FA-4ECF-998C-19BE4D33BD15Q35986531-F2813F4E-8705-4307-B01B-3FBA9E4A9F83Q36785320-A961D917-3BB9-45A1-ABA6-396A38257A2AQ37058267-F6C18A00-29A0-4519-BD30-999D3366309CQ38260561-391DE800-A7E9-4A1B-98F2-E1C776BDBC32Q38267868-64A92DE2-EBC3-48AD-B8F8-F1628250D334Q38579499-FA2FDDCA-A224-40AF-8B74-CB639E276A81Q38587970-7110E7C7-BEA3-4892-9285-F5E059A01E92Q38702278-F1500380-7923-46FC-9F37-D4E3AA35C237Q38853625-3BCF4A93-01E2-40EA-9621-FCACD45E9A2FQ38887581-EE4C697D-6269-44DA-8B1F-A34B6EFC4BE9Q39646982-B570BFB9-9D87-4928-A57D-D8D8F344D38AQ40433122-A53065FC-662C-4DF9-8B8E-E36AE9F136FCQ41585035-4D790DE1-AC8D-4445-866E-2A6187B4A306Q51150626-5B3CB0DA-0EAC-4BBE-93AB-EEFF273D0533Q57115352-A7F687EF-2105-4D79-A9C0-873D54E096DAQ58122535-0C7A161F-BAA6-47F7-8D56-74503DAFC4D0Q58694027-A5FD6ACF-48CC-41CD-91B4-A570D05A65C8
P2860
Tocilizumab, a proposed therapy for the cachexia of Interleukin6-expressing lung cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Tocilizumab, a proposed therapy for the cachexia of Interleukin6-expressing lung cancer
@ast
Tocilizumab, a proposed therapy for the cachexia of Interleukin6-expressing lung cancer
@en
type
label
Tocilizumab, a proposed therapy for the cachexia of Interleukin6-expressing lung cancer
@ast
Tocilizumab, a proposed therapy for the cachexia of Interleukin6-expressing lung cancer
@en
prefLabel
Tocilizumab, a proposed therapy for the cachexia of Interleukin6-expressing lung cancer
@ast
Tocilizumab, a proposed therapy for the cachexia of Interleukin6-expressing lung cancer
@en
P2093
P2860
P1433
P1476
Tocilizumab, a proposed therapy for the cachexia of Interleukin6-expressing lung cancer
@en
P2093
Fumiaki Koizumi
Fumiyuki Takahashi
Katsutoshi Ando
Kazuhisa Takahashi
Kazuto Nishio
Motoyasu Kato
Norihiro Kaneko
Tokuhide Doi
Yuichiro Ohe
P2860
P304
P356
10.1371/JOURNAL.PONE.0102436
P407
P577
2014-07-10T00:00:00Z